MTOR and lymphangioleiomyomatosis: Small Molecule Inhibitors: mTOR inhibitors like rapamycin indirectly suppress GPNMB in lymphangioleiomyomatosis (LAM), reducing tumor growth by 60% in murine models (Gibbons et al., 2024).